Lidocaine Clinical Trials
Conditions / Lidocaine
Delta Trials tracks 61 clinical trials for Lidocaine in its publicly accessible dataset. Among the listed trials, 6 open for participant enrollment and 28 trials have reached completion. This research is carried out at 34 clinical sites around the world. An additional 27 trials have active registrations outside the recruiting and completed categories. Since 2020, 1 trial have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
61
Total Trials
6
Recruiting
28
Completed
27
Other Active
1
Terminated since 2020
34
Study Locations
Browse by location (34 total)
- Cairo, Egypt 8 trialsAll trials in Cairo, Egypt
- Athens, Greece 6 trialsAll trials in Athens, Greece
- Athens, Greece 6 trialsAll trials in Athens, Greece
- Tanta, Egypt 5 trialsAll trials in Tanta, Egypt
- Taipei, Taiwan 4 trialsAll trials in Taipei, Taiwan
- Taipei, Taiwan 4 trialsAll trials in Taipei, Taiwan
- Beijing, China 3 trialsAll trials in Beijing, China
- Saskatoon, Canada 3 trialsAll trials in Saskatoon, Canada
- Anqing, China 3 trialsAll trials in Anqing, China
- Aalborg, Denmark 2 trialsAll trials in Aalborg, Denmark
- Alexandria, Egypt 2 trialsAll trials in Alexandria, Egypt
- Guangzhou, China 2 trialsAll trials in Guangzhou, China
- Giza, Egypt 2 trialsAll trials in Giza, Egypt
- Nai Muang, Thailand 1 trialAll trials in Nai Muang, Thailand
- Yangzhou, China 1 trialAll trials in Yangzhou, China
- Beirut, Lebanon 1 trialAll trials in Beirut, Lebanon
- Lahore, Pakistan 1 trialAll trials in Lahore, Pakistan
- Taoyuan, Taiwan 1 trialAll trials in Taoyuan, Taiwan
- Winnipeg, Canada 1 trialAll trials in Winnipeg, Canada
- Kocaeli, Turkey (türkiye) 1 trialAll trials in Kocaeli, Turkey (türkiye)